‘Stem-Cell Tourism’ Needs Tighter Controls, Say Medical Experts

July 6, 2017

(Reuters) – Stem-cell tourism involving patients who travel to developing countries for treatment with unproven and potentially risky therapies should be more tightly regulated, international health experts said on Wednesday. With hundreds of medical centers around the world claiming to be able to repair damaged tissue in conditions such as multiple sclerosis and Parkinson’s disease, tackling unscrupulous advertising of such procedures is crucial.

Recommended Reading